Stories
Prime Therapeutics ranked No. 3 on Minnesota top private companies list
September 15, 2023
The Minneapolis/St. Paul Business Journal named Prime Therapeutics (Prime) to its annual list, Minnesota’s 100 Largest Private Companies. For fiscal year 2022, Prime earned the No. 3 position.
The Journal’s once yearly list ranks companies by revenue. To qualify for the ranking, a company must have headquarters in Minnesota, be a for-profit operation and not issue stock to the public.
The full Minnesota’s 100 Largest Private Companies list is available now online and will publish in the Minneapolis/St. Paul Business Journal’s annual Book of Lists later this year.
Related news
Stories
July 22, 2024
Introducing the latest issue of our medical and pharmacy benefit management report
The summer 2024 issue of the Magellan Rx Report provides insights on the industry’s most groundbreaking managed care solutions in some of the most complex areas of health care
Stories
July 18, 2024
Specialty drug trend forecasted to drop for employer groups, clinical experts say
Introduction of Humira® and Stelara® biosimilars contribute to continued decline in the autoimmune – anti-inflammatory trend
Stories
July 16, 2024
Prime/Magellan Rx earns top score on the Disability Equality Index
For the second consecutive year, Prime Therapeutics/Magellan Rx Management received a score of 100 on the Disability Equality Index®, which benchmarks disability workplace inclusion